Thibaudin, M., Roussot, N., Burlot, C., Schmitt, A., Vincent, J., Tharin, Z., . . . Ghiringhelli, F. Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): A single-center phase 1 trial. Nature Publishing Group.
Chicago Style (17th ed.) CitationThibaudin, Marion, et al. Safety and Efficacy of Trifluridine/tipiracil +/− bevacizumab Plus XB2001 (anti-IL-1α Antibody): A Single-center Phase 1 Trial. Nature Publishing Group.
MLA (9th ed.) CitationThibaudin, Marion, et al. Safety and Efficacy of Trifluridine/tipiracil +/− bevacizumab Plus XB2001 (anti-IL-1α Antibody): A Single-center Phase 1 Trial. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.